» Authors » Shuo-Fu Chen

Shuo-Fu Chen

Explore the profile of Shuo-Fu Chen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 13
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen S, Ng P, Lai C, Wang F, Wang Y, Chen M, et al.
J Nanobiotechnology . 2025 Feb; 23(1):105. PMID: 39940015
Background: Radiotherapy plays an important role in the treatment of triple-negative breast cancer, yet its ability to trigger systemic responses against distant tumors remains limited. Results: To address this challenge,...
2.
Chen S, Wang L, Lin Y, Chen C
J Ovarian Res . 2025 Jan; 18(1):15. PMID: 39876016
No abstract available.
3.
Chen S, Yang S, Jiang J, Wang L
J Surg Oncol . 2024 Dec; PMID: 39635915
Background And Objectives: The watch-and-wait (WW) strategy is a nonsurgical alternative for patients with rectal cancer exhibiting an excellent response to chemoradiotherapy. Studies on the WW strategy have primarily investigated...
4.
Chen S, Cheng W, Chao C, Kuo C, Liao R
Pharmacol Biochem Behav . 2024 Nov; 245():173904. PMID: 39522650
N-methyl-d-aspartate (NMDA) receptors, activated by glutamate, play a crucial role in learning and memory. Memantine (MEM), a non-competitive NMDA receptor antagonist, is currently prescribed for the treatment of Alzheimer's disease...
5.
Xiao M, Zhu Y, Gao W, Zeng Y, Li H, Chen S, et al.
Huan Jing Ke Xue . 2024 Oct; 45(10):5761-5767. PMID: 39455122
The prediction of future data using existing data is an effective tool for regional planning and watershed management. The back propagation neural network (BPNN) and convolutional neural network (CNN) were...
6.
Chen S, Wang L, Lin Y, Chen C
J Ovarian Res . 2024 Sep; 17(1):190. PMID: 39342345
Background: Personalized medicine remains an unmet need in ovarian cancer due to its heterogeneous nature and complex immune microenvironments, which has gained increasing attention in the era of immunotherapy. A...
7.
Chen S, Kau M, Wang Y, Chen M, Tung F, Chen M, et al.
Int J Nanomedicine . 2023 Dec; 18:7677-7693. PMID: 38111846
Purpose: Glioblastoma is a highly aggressive brain tumor with universally poor outcomes. Recent progress in immune checkpoint inhibitors has led to increased interest in their application in glioblastoma. Nonetheless, the...
8.
Chen S, Yeh F, Chen C, Chang H
Clin Proteomics . 2023 Jun; 20(1):22. PMID: 37301840
Unpredictable treatment responses have been an obstacle for the successful management of rheumatoid arthritis. Although numerous serum proteins have been proposed, there is a lack of integrative survey to compare...
9.
Chen C, Chen S, Tsai H, Chen Y, Tang S, Jeng J
Cerebrovasc Dis . 2023 Jun; 53(2):136-143. PMID: 37263251
Introduction: Several early noncontrast CT (NCCT) signs of spontaneous intracerebral hemorrhage (ICH) can predict hematoma expansion (HE). However, the associations of underlying cerebral small vessel disease (SVD) on early NCCT...
10.
Chen S, Hsu W, Lu X, Chuang C, Liao R
Psychopharmacology (Berl) . 2021 Nov; 239(5):1459-1473. PMID: 34741633
Rationale: In human beings and experimental animals, maladaptive impulsivity is manifested by the acute injection of psychostimulants, such as amphetamine. Cannabinoid CB1 receptors have been implicated in the regulation of...